FDA: Limit pregnant women's, children's exposure to anesthesia

The Food and Drug Administration issued a drug safety announcement Wednesday warning that lengthy use of sedation or anesthetic drugs in pregnant women during the third trimester and children under 3 years old can have adverse effects on children's brains.

The FDA will now require warnings on the labels of general anesthetic and sedation drugs. The agency urges healthcare providers to "balance the benefits of appropriate anesthesia in young children and pregnant women against potential risks," especially if the exposure will be longer than 3 hours or if multiple procedures are needed.

According to the FDA, human studies have shown a single, short exposure to such drugs for infants and toddlers likely won't have adverse effects, but further research is needed.

View the safety warning here.

More articles on patient safety:
7 hospitals notifying patients of heater-cooler infection risks
Redefining patient safety in 2017 — 6 thoughts from IHI CEO Derek Feeley
Tenet hospital's Medicare funding no longer in jeopardy

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.